Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trialsLuis Ortega‐Paz, Dominick J. Angiolillo, Renato D. Lópes et al.|European Heart Journal - Cardiovascular Pharmacotherapy|2021Cited by 72
Factor XI Inhibitors in Early Clinical Trials: A Meta-analysisMattía Galli, Dominick J. Angiolillo, Luis Ortega‐Paz et al.|Thrombosis and Haemostasis|2023Cited by 62
Precision Medicine in Interventional Cardiology: Implications for Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary InterventionMattía Galli, Dominick J. Angiolillo, Luis Ortega‐Paz et al.|Pharmacogenomics|2022Cited by 48
Cardiovascular Effects and Tolerability of GLP-1 Receptor AgonistsMattía Galli, Sebastiano Sciarretta, Luis Ortega‐Paz et al.|Journal of the American College of Cardiology|2025Cited by 48